| Record ID | marc_columbia/Columbia-extract-20221130-016.mrc:167243394:2910 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-016.mrc:167243394:2910?format=raw |
LEADER: 02910pam a2200361 a 4500
001 7932468
005 20221201045309.0
008 100526s2010 paua b 001 0 eng
015 $aGBB067850$2bnb
016 7 $a015566934$2Uk
020 $a9781437726176 (hbk.)
020 $a1437726178 (hbk.)
029 1 $aNLGGC$b328749001
035 $a(OCoLC)ocn656763286
035 $a(OCoLC)656763286
035 $a(NNC)7932468
035 $a7932468
040 $aUKM$cUKM$dNNC-M$dOrLoB-B
042 $aukblcatcopy
082 04 $a616.99449059$222
245 00 $aEarly-stage breast cancer :$bnew developments and controversies /$cguest editor, Eleftherios P. Mamounas ; consulting editor, Nicholas J. Petrelli.
260 $aPhiladelphia, Pa. :$bSaunders,$c2010.
300 $axvi, pages 465-689 :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aSurgical oncology clinics of North America ;$vv. 19, no. 3
504 $aIncludes bibliographical references and index.
505 00 $tForeword /$rNicholas J. Petrelli -- $tPreface /$rEleftherios P. Mamounas -- $tBreast Cancer Chemoprevention: Progress and Controversy /$rD. Lawrence Wickerham -- $tMagnetic Resonance Imaging for Screening, Diagnosis, and Eligibility for Breast-conserving Surgery: Promises and Pitfalls /$rMonica Morrow -- $tClinical Significance of Minimal Sentinel Node Involvement and Management Options /$rAnees B. Chagpar -- $tClinical Significance and Management of Extra-Axillary Sentinel Lymph Nodes: Worthwhile or Irrelevant? /$rHiram S. Cody III -- $tSentinel Lymph Node Biopsy Before or After Neoadjuvant Chemotherapy: Pros and Cons /$rMichael S. Sabel -- $tSentinel Lymph Node Surgery in Uncommon Clinical Circumstances /$rJudy C. Boughey -- $tTotal Skin Sparing (Nipple Sparing) Mastectomy: What is the Evidence? /$rPatrick Ivan Borgen -- $tOncoplastic Surgery: A Creative Approach to Breast Cancer Management /$rGail S. Lebovic -- $tClinical Application of Gene Expression Profiling in Breast Cancer /$rParaic A. Kenny -- $tNeoadjuvant Chemotherapy for Operable Breast Cancer: Individualizing Locoregional and Systemic Therapy /$rHarry D. Bear -- $tNeoadjuvant Endocrine Therapy for Breast Cancer /$rMatthew J. Ellis -- $tAdjuvant Hormonal Therapy for Early-Stage Breast Cancer /$rJennifer J. Griggs -- $tAdjuvant Chemotherapy in Early-Stage Breast Cancer: What, When, and for Whom? /$rGabriel N. Hortobagyi -- $tTargeted Therapies in Early-Stage Breast Cancer: Achievements and Promises /$rLinda Mina.
650 0 $aBreast$xCancer$xSurgery.$0http://id.loc.gov/authorities/subjects/sh85016680
650 12 $aBreast Neoplasms$xsurgery.$0https://id.nlm.nih.gov/mesh/D001943Q000601
700 1 $aMamounas, Eleftherios P.$0http://id.loc.gov/authorities/names/no2008134174
830 0 $aSurgical oncology clinics of North America ;$vv. 19, no. 3.
852 80 $boff,hsr$hSerial$iS